| Year |
Citation |
Score |
| 2024 |
Haga CL, Booker CN, Strivelli J, Boregowda SV, Phinney DG. Comparative transcriptome analysis of bone marrow resident versus culture-expanded mouse mesenchymal stem/stromal cells. Cytotherapy. PMID 38372680 DOI: 10.1016/j.jcyt.2024.01.008 |
0.438 |
|
| 2023 |
Boregowda SV, Haga CL, Supper VM, Booker CN, Phinney DG. Novel role for alpha-2-macroglobulin (A2M) as a disease modifying protein in senile osteoporosis. Frontiers in Cell and Developmental Biology. 11: 1294438. PMID 37965574 DOI: 10.3389/fcell.2023.1294438 |
0.34 |
|
| 2023 |
Lee RH, Boregowda SV, Shigemoto-Kuroda T, Bae E, Haga CL, Abbery CA, Bayless KJ, Haskell A, Gregory CA, Ortiz LA, Phinney DG. and are coordinately regulated and function as potency biomarkers in human MSCs. Science Advances. 9: eadi2387. PMID 37948519 DOI: 10.1126/sciadv.adi2387 |
0.363 |
|
| 2023 |
Haga CL, Booker CN, Carvalho A, Boregowda SV, Phinney DG. Transcriptional Targets of TWIST1 in Human Mesenchymal Stem/Stromal Cells Mechanistically Link Stem/Progenitor and Paracrine Functions. Stem Cells (Dayton, Ohio). PMID 37665974 DOI: 10.1093/stmcls/sxad070 |
0.398 |
|
| 2023 |
Phinney DG, Lee RH, Boregowda SV. Revisiting the Mesenchymal "Stem vs. Stromal" Cell Dichotomy and Its Implications for Development of Improved Potency Metrics. Stem Cells (Dayton, Ohio). PMID 36891977 DOI: 10.1093/stmcls/sxad019 |
0.396 |
|
| 2021 |
Booker CN, Haga CL, Boregowda SV, Strivelli J, Phinney DG. Transcriptional responses of skeletal stem/progenitor cells to hindlimb unloading and recovery correlate with localized but not systemic multi-systems impacts. Npj Microgravity. 7: 49. PMID 34836964 DOI: 10.1038/s41526-021-00178-0 |
0.336 |
|
| 2021 |
Pathipati P, Lecuyer M, Faustino J, Strivelli J, Phinney DG, Vexler ZS. Mesenchymal Stem Cell (MSC)-Derived Extracellular Vesicles Protect from Neonatal Stroke by Interacting with Microglial Cells. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 34235636 DOI: 10.1007/s13311-021-01076-9 |
0.355 |
|
| 2021 |
Viswanathan S, Ciccocioppo R, Galipeau J, Krampera M, Le Blanc K, Martin I, Moniz K, Nolta J, Phinney DG, Shi Y, Szczepiorkowski ZM, Tarte K, Weiss DJ, Ashford P. Consensus International Council for Commonality in Blood Banking Automation-International Society for Cell & Gene Therapy statement on standard nomenclature abbreviations for the tissue of origin of mesenchymal stromal cells. Cytotherapy. PMID 34116944 DOI: 10.1016/j.jcyt.2021.04.009 |
0.368 |
|
| 2021 |
Dorronsoro A, Santiago FE, Grassi D, Zhang T, Lai RC, McGowan SJ, Angelini L, Lavasani M, Corbo L, Lu A, Brooks RW, Garcia-Contreras M, Stolz DB, Amelio A, Boregowda SV, ... ... Phinney DG, et al. Mesenchymal stem cell-derived extracellular vesicles reduce senescence and extend health span in mouse models of aging. Aging Cell. e13337. PMID 33728821 DOI: 10.1111/acel.13337 |
0.431 |
|
| 2021 |
Galipeau J, Krampera M, Leblanc K, Nolta JA, Phinney DG, Shi Y, Tarte K, Viswanathan S, Martin I. Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition. Cytotherapy. PMID 33714704 DOI: 10.1016/j.jcyt.2020.11.007 |
0.308 |
|
| 2020 |
Khoury M, Rocco PRM, Phinney DG, Krampera M, Martin I, Viswanathan S, Nolta JA, LeBlanc K, Galipeau J, Weiss DJ. Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential. Cytotherapy. PMID 32933835 DOI: 10.1016/J.Jcyt.2020.04.089 |
0.358 |
|
| 2020 |
Börger V, Weiss DJ, Anderson JD, Borràs FE, Bussolati B, Carter DRF, Dominici M, Falcón-Pérez JM, Gimona M, Hill AF, Hoffman AM, de Kleijn D, Levine BL, Lim R, Lötvall J, ... ... Phinney DG, et al. ISEV and ISCT statement on EVs from MSCs and other cells: considerations for potential therapeutic agents to suppress COVID-19. Cytotherapy. PMID 32425691 DOI: 10.1016/J.Jcyt.2020.05.002 |
0.395 |
|
| 2020 |
Nolta JA, Galipeau J, Phinney DG. Improving mesenchymal stem/stromal cell potency and survival: Proceedings from the International Society of Cell Therapy (ISCT) MSC preconference held in May 2018, Palais des Congrès de Montréal, Organized by the ISCT MSC Scientific Committee. Cytotherapy. PMID 32067856 DOI: 10.1016/J.Jcyt.2020.01.004 |
0.485 |
|
| 2019 |
Pittenger MF, Discher DE, Péault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. Npj Regenerative Medicine. 4: 22. PMID 31815001 DOI: 10.1038/S41536-019-0083-6 |
0.527 |
|
| 2019 |
Viswanathan S, Shi Y, Galipeau J, Krampera M, Leblanc K, Martin I, Nolta J, Phinney DG, Sensebe L. Mesenchymal stem versus stromal cells: International Society for Cellular Therapy Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy. PMID 31526643 DOI: 10.1016/J.Jcyt.2019.08.002 |
0.524 |
|
| 2019 |
Phinney DG, Galipeau J. Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at U.S. academic centers. Cytotherapy. PMID 31182333 DOI: 10.1016/J.Jcyt.2019.04.003 |
0.382 |
|
| 2019 |
Ortiz L, Njah J, Marrocco A, Detweiler A, Milosevic J, Phinney D, Lai R, Choo A, Tan S, Lim S. Mesenchymal stem cells (hMSC) exosomes couple the RV/PA during Pulmonary fibrosis (PF) Cytotherapy. 21: S15. DOI: 10.1016/J.Jcyt.2019.03.580 |
0.306 |
|
| 2018 |
Boregowda SV, Krishnappa V, Strivelli J, Haga CL, Booker CN, Phinney DG. Basal p53 expression is indispensable for mesenchymal stem cell integrity. Cell Death and Differentiation. PMID 29311623 DOI: 10.1038/S41418-017-0004-4 |
0.527 |
|
| 2017 |
Boregowda SV, Booker CN, Phinney DG. Mesenchymal Stem Cells: The Moniker Fits the Science. Stem Cells (Dayton, Ohio). PMID 28960677 DOI: 10.1002/Stem.2713 |
0.504 |
|
| 2017 |
Boregowda SV, Ghoshal S, Booker CN, Krishnappa V, Chakraborty A, Phinney DG. IP6K1 Reduces Mesenchymal Stem/Stromal Cell Fitness and Potentiates High Fat Diet-Induced Skeletal Involution. Stem Cells (Dayton, Ohio). PMID 28577302 DOI: 10.1002/Stem.2645 |
0.465 |
|
| 2017 |
Phinney DG. Mesenchymal stromal cells and ischemic heart disease: hitting the target? Cardiovascular Diagnosis and Therapy. 7: E4-E6. PMID 28567365 DOI: 10.21037/Cdt.2016.12.04 |
0.316 |
|
| 2017 |
Phinney DG, Pittenger MF. Concise Review: MSC-Derived Exosomes for Cell-Free Therapy. Stem Cells (Dayton, Ohio). PMID 28294454 DOI: 10.1002/Stem.2575 |
0.528 |
|
| 2017 |
Phinney DG. Advancing mesenchymal stem/stromal cells-based therapies for neurologic disease. Neural Regeneration Research. 12: 60-61. PMID 28250743 DOI: 10.4103/1673-5374.198978 |
0.447 |
|
| 2017 |
Isakova IA, Baker KC, Dufour J, Phinney DG. Mesenchymal Stem Cells Yield Transient Improvements in Motor Function in an Infant Rhesus Macaque with Severe Early-Onset Krabbe Disease. Stem Cells Translational Medicine. 6: 99-109. PMID 28170189 DOI: 10.5966/Sctm.2015-0317 |
0.381 |
|
| 2017 |
Booker C, Boregowda S, Phinney D. Effects of simulated microgravity on the frequency and function of marrow resident mesenchymal stem cells Cytotherapy. 19: S151. DOI: 10.1016/J.Jcyt.2017.02.228 |
0.443 |
|
| 2017 |
Boregowda S, Krishnappa V, Booker C, Phinney D. Interruption of FGFR2 signaling licenses the immuno-modulatory activity of human MSCs by suppressing TWIST1 expression Cytotherapy. 19: S28. DOI: 10.1016/J.Jcyt.2017.02.057 |
0.365 |
|
| 2016 |
Boregowda SV, Krishnappa V, Phinney DG. Isolation of Mouse Bone Marrow Mesenchymal Stem Cells. Methods in Molecular Biology (Clifton, N.J.). 1416: 205-23. PMID 27236673 DOI: 10.1007/978-1-4939-3584-0_11 |
0.52 |
|
| 2016 |
Boregowda SV, Krishnappa V, Haga CL, Ortiz LA, Phinney DG. A Clinical Indications Prediction Scale Based on TWIST1 for Human Mesenchymal Stem Cells. Ebiomedicine. 4: 62-73. PMID 26981553 DOI: 10.1016/J.Ebiom.2015.12.020 |
0.505 |
|
| 2015 |
Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, Dominici M, Fibbe WE, Gee AP, Gimble JM, Hematti P, Koh MB, LeBlanc K, Martin I, McNiece IK, ... ... Phinney DG, et al. International society for cellular therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy. PMID 26724220 DOI: 10.1016/J.Jcyt.2015.11.008 |
0.401 |
|
| 2015 |
Yang R, Piperdi S, Zhang Y, Zhu W, Neophytou N, Hoang BH, Mason G, Geller D, Dorfman H, Meyers PA, Healey JH, Phinney DG, Gorlick R. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-β as Involved in the Pathogenesis of Osteosarcoma. Clinical Orthopaedics and Related Research. PMID 26463566 DOI: 10.1007/S11999-015-4578-1 |
0.333 |
|
| 2015 |
Phinney DG, Di Giuseppe M, Njah J, Sala E, Shiva S, St Croix CM, Stolz DB, Watkins SC, Di YP, Leikauf GD, Kolls J, Riches DW, Deiuliis G, Kaminski N, Boregowda SV, et al. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nature Communications. 6: 8472. PMID 26442449 DOI: 10.1038/Ncomms9472 |
0.503 |
|
| 2015 |
Pittenger MF, Le Blanc K, Phinney DG, Chan JK. MSCs: Scientific Support for Multiple Therapies. Stem Cells International. 2015: 280572. PMID 26294916 DOI: 10.1155/2015/280572 |
0.536 |
|
| 2015 |
Haga CL, Velagapudi SP, Strivelli JR, Yang WY, Disney MD, Phinney DG. Small Molecule Inhibition of miR-544 Biogenesis Disrupts Adaptive Responses to Hypoxia by Modulating ATM-mTOR Signaling. Acs Chemical Biology. PMID 26181590 DOI: 10.1021/Acschembio.5B00265 |
0.315 |
|
| 2015 |
Marciano DP, Kuruvilla DS, Boregowda SV, Asteian A, Hughes TS, Garcia-Ordonez R, Corzo CA, Khan TM, Novick SJ, Park H, Kojetin DJ, Phinney DG, Bruning JB, Kamenecka TM, Griffin PR. Pharmacological repression of PPARγ promotes osteogenesis. Nature Communications. 6: 7443. PMID 26068133 DOI: 10.1038/Ncomms8443 |
0.409 |
|
| 2014 |
Phinney DG, Isakova IA. Mesenchymal stem cells as cellular vectors for pediatric neurological disorders. Brain Research. 1573: 92-107. PMID 24858930 DOI: 10.1016/J.Brainres.2014.05.029 |
0.507 |
|
| 2014 |
Zhao W, Phinney DG, Bonnet D, Dominici M, Krampera M. Mesenchymal stem cell biodistribution, migration, and homing in vivo. Stem Cells International. 2014: 292109. PMID 24738002 DOI: 10.1155/2014/292109 |
0.519 |
|
| 2014 |
Fazzi F, Njah J, Di Giuseppe M, Winnica DE, Go K, Sala E, St Croix CM, Watkins SC, Tyurin VA, Phinney DG, Fattman CL, Leikauf GD, Kagan VE, Ortiz LA. TNFR1/phox interaction and TNFR1 mitochondrial translocation Thwart silica-induced pulmonary fibrosis. Journal of Immunology (Baltimore, Md. : 1950). 192: 3837-46. PMID 24623132 DOI: 10.4049/Jimmunol.1103516 |
0.308 |
|
| 2014 |
Isakova IA, Lanclos C, Bruhn J, Kuroda MJ, Baker KC, Krishnappa V, Phinney DG. Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment in vivo Plos One. 9. PMID 24489878 DOI: 10.1371/Journal.Pone.0087238 |
0.43 |
|
| 2014 |
Krishnappa V, Boregowda S, Phinney D. FGF2 protects mouse mesenchymal stem cells from oxidative stress by modulating a twist2-p53 signaling axis Cytotherapy. 16: S74. DOI: 10.1016/J.Jcyt.2014.01.273 |
0.411 |
|
| 2013 |
Krishnappa V, Boregowda SV, Phinney DG. The peculiar biology of mouse mesenchymal stromal cells--oxygen is the key. Cytotherapy. 15: 536-41. PMID 23352463 DOI: 10.1016/J.Jcyt.2012.11.018 |
0.479 |
|
| 2013 |
Phinney DG, Sensebé L. Mesenchymal stromal cells: misconceptions and evolving concepts. Cytotherapy. 15: 140-5. PMID 23321325 DOI: 10.1016/J.Jcyt.2012.11.005 |
0.514 |
|
| 2012 |
Boregowda SV, Phinney DG. Therapeutic applications of mesenchymal stem cells: current outlook. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 26: 201-8. PMID 22708790 DOI: 10.2165/11632790-000000000-00000 |
0.471 |
|
| 2012 |
Phinney DG. Functional heterogeneity of mesenchymal stem cells: implications for cell therapy. Journal of Cellular Biochemistry. 113: 2806-12. PMID 22511358 DOI: 10.1002/Jcb.24166 |
0.512 |
|
| 2012 |
Boregowda SV, Krishnappa V, Chambers JW, Lograsso PV, Lai WT, Ortiz LA, Phinney DG. Atmospheric oxygen inhibits growth and differentiation of marrow-derived mouse mesenchymal stem cells via a p53-dependent mechanism: implications for long-term culture expansion. Stem Cells (Dayton, Ohio). 30: 975-87. PMID 22367737 DOI: 10.1002/Stem.1069 |
0.711 |
|
| 2012 |
Sensebé L, Tarte K, Galipeau J, Krampera M, Martin I, Phinney DG, Shi Y. Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells. Cell Stem Cell. 10: 9-10; author reply 1. PMID 22226349 DOI: 10.1016/J.Stem.2011.12.005 |
0.362 |
|
| 2011 |
O'Connor KC, Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE. High-capacity assay to quantify the clonal heterogeneity in potency of mesenchymal stem cells. Bmc Proceedings. 5: O14. PMID 22373225 DOI: 10.1186/1753-6561-5-S8-O14 |
0.539 |
|
| 2011 |
Lai WT, Krishnappa V, Phinney DG. Fibroblast growth factor 2 (Fgf2) inhibits differentiation of mesenchymal stem cells by inducing Twist2 and Spry4, blocking extracellular regulated kinase activation, and altering Fgf receptor expression levels. Stem Cells (Dayton, Ohio). 29: 1102-11. PMID 21608080 DOI: 10.1002/Stem.661 |
0.715 |
|
| 2011 |
Russell KC, Lacey MR, Gilliam JK, Tucker HA, Phinney DG, O'Connor KC. Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency. Biotechnology and Bioengineering. 108: 2716-26. PMID 21538337 DOI: 10.1002/Bit.23193 |
0.525 |
|
| 2011 |
Phinney DG. Twist, epithelial-to-mesenchymal transition, and stem cells. Stem Cells (Dayton, Ohio). 29: 3-4. PMID 21280153 DOI: 10.1002/Stem.553 |
0.558 |
|
| 2011 |
Savitz SI, Chopp M, Deans R, Carmichael ST, Phinney D, Wechsler L. Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II Stroke. 42: 825-829. PMID 21273569 DOI: 10.1161/Strokeaha.110.601914 |
0.331 |
|
| 2010 |
Prockop DJ, Brenner M, Fibbe WE, Horwitz E, Le Blanc K, Phinney DG, Simmons PJ, Sensebe L, Keating A. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy. 12: 576-8. PMID 20735162 DOI: 10.3109/14653249.2010.507330 |
0.422 |
|
| 2010 |
Isakova IA, Dufour J, Lanclos C, Bruhn J, Phinney DG. Cell-dose-dependent increases in circulating levels of immune effector cells in rhesus macaques following intracranial injection of allogeneic MSCs. Experimental Hematology. 38: 957-967.e1. PMID 20600575 DOI: 10.1016/J.Exphem.2010.06.011 |
0.438 |
|
| 2010 |
Barrilleaux BL, Fischer-Valuck BW, Gilliam JK, Phinney DG, O'Connor KC. Activation of CD74 inhibits migration of human mesenchymal stem cells. In Vitro Cellular & Developmental Biology. Animal. 46: 566-72. PMID 20198449 DOI: 10.1007/S11626-010-9279-1 |
0.429 |
|
| 2010 |
Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O'Connor KC. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells (Dayton, Ohio). 28: 788-98. PMID 20127798 DOI: 10.1002/Stem.312 |
0.529 |
|
| 2010 |
Fischer-Valuck BW, Barrilleaux BL, Phinney DG, Russell KC, Prockop DJ, O'Connor KC. Migratory response of mesenchymal stem cells to macrophage migration inhibitory factor and its antagonist as a function of colony-forming efficiency. Biotechnology Letters. 32: 19-27. PMID 19705068 DOI: 10.1007/S10529-009-0110-6 |
0.517 |
|
| 2009 |
Phinney DG. A SAGE View of Mesenchymal Stem Cells. International Journal of Stem Cells. 2: 1-10. PMID 24855514 DOI: 10.15283/Ijsc.2009.2.1.1 |
0.544 |
|
| 2009 |
Barrilleaux BL, Phinney DG, Fischer-Valuck BW, Russell KC, Wang G, Prockop DJ, O'Connor KC. Small-molecule antagonist of macrophage migration inhibitory factor enhances migratory response of mesenchymal stem cells to bronchial epithelial cells. Tissue Engineering. Part A. 15: 2335-46. PMID 19260777 DOI: 10.1089/Ten.Tea.2008.0434 |
0.495 |
|
| 2009 |
Phinney D, Isakova I, Dutreil M. 104. Exploiting mesenchymal stem cell biology for neurologic disorders Molecular Genetics and Metabolism. 96: S35. DOI: 10.1016/J.Ymgme.2008.11.105 |
0.454 |
|
| 2008 |
Daher SR, Johnstone BH, Phinney DG, March KL. Adipose stromal/stem cells: basic and translational advances: the IFATS collection. Stem Cells (Dayton, Ohio). 26: 2664-5. PMID 18818434 DOI: 10.1634/Stemcells.2008-0927 |
0.484 |
|
| 2008 |
Phinney DG. Isolation of mesenchymal stem cells from murine bone marrow by immunodepletion. Methods in Molecular Biology (Clifton, N.J.). 449: 171-86. PMID 18370091 DOI: 10.1007/978-1-60327-169-1_12 |
0.516 |
|
| 2008 |
Phinney DG, Stojković M. Stem Cells Appoints Four Associate Editors Stem Cells. 26: 1095-1096. DOI: 10.1634/Stemcells.2008-0340 |
0.472 |
|
| 2007 |
Phinney DG. Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic efficacy. Cell Cycle (Georgetown, Tex.). 6: 2884-9. PMID 18000405 DOI: 10.4161/Cc.6.23.5095 |
0.536 |
|
| 2007 |
Isakova IA, Baker K, DuTreil M, Dufour J, Gaupp D, Phinney DG. Age- and dose-related effects on MSC engraftment levels and anatomical distribution in the central nervous systems of nonhuman primates: identification of novel MSC subpopulations that respond to guidance cues in brain. Stem Cells (Dayton, Ohio). 25: 3261-70. PMID 17932418 DOI: 10.1634/Stemcells.2007-0543 |
0.431 |
|
| 2007 |
Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells (Dayton, Ohio). 25: 2896-902. PMID 17901396 DOI: 10.1634/Stemcells.2007-0637 |
0.533 |
|
| 2007 |
Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proceedings of the National Academy of Sciences of the United States of America. 104: 11002-7. PMID 17569781 DOI: 10.1073/Pnas.0704421104 |
0.404 |
|
| 2007 |
Kang SK, Yeo JE, Kang KS, Phinney DG. Cytoplasmic extracts from adipose tissue stromal cells alleviates secondary damage by modulating apoptosis and promotes functional recovery following spinal cord injury. Brain Pathology (Zurich, Switzerland). 17: 263-75. PMID 17465991 DOI: 10.1111/J.1750-3639.2007.00070.X |
0.314 |
|
| 2007 |
Zwezdaryk KJ, Coffelt SB, Figueroa YG, Liu J, Phinney DG, LaMarca HL, Florez L, Morris CB, Hoyle GW, Scandurro AB. Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells. Experimental Hematology. 35: 640-52. PMID 17379074 DOI: 10.1016/J.Exphem.2007.01.044 |
0.416 |
|
| 2007 |
Pandey AC, Dutreil MF, Phinney DG. ENDOGENOUS EXPRESSION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST ISOFORMS BY MURINE MESENCHYMAL STEM CELLS. Journal of Investigative Medicine. 55: S288-S289. DOI: 10.1097/00042871-200701010-00765 |
0.419 |
|
| 2006 |
Barrilleaux B, Phinney DG, Prockop DJ, O'Connor KC. Review: ex vivo engineering of living tissues with adult stem cells. Tissue Engineering. 12: 3007-19. PMID 17518617 DOI: 10.1089/Ten.2006.12.3007 |
0.517 |
|
| 2006 |
Phinney DG, Baddoo M, Dutreil M, Gaupp D, Lai WT, Isakova IA. Murine mesenchymal stem cells transplanted to the central nervous system of neonatal versus adult mice exhibit distinct engraftment kinetics and express receptors that guide neuronal cell migration. Stem Cells and Development. 15: 437-47. PMID 16846379 DOI: 10.1089/Scd.2006.15.437 |
0.718 |
|
| 2006 |
Isakova IA, Baker K, Dufour J, Gaupp D, Phinney DG. Preclinical evaluation of adult stem cell engraftment and toxicity in the CNS of rhesus macaques. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 1173-84. PMID 16497561 DOI: 10.1016/J.Ymthe.2005.12.014 |
0.463 |
|
| 2006 |
Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Experimental Neurology. 198: 54-64. PMID 16336965 DOI: 10.1016/J.Expneurol.2005.10.029 |
0.473 |
|
| 2006 |
Phinney DG, Hill K, Michelson C, DuTreil M, Hughes C, Humphries S, Wilkinson R, Baddoo M, Bayly E. Biological activities encoded by the murine mesenchymal stem cell transcriptome provide a basis for their developmental potential and broad therapeutic efficacy. Stem Cells (Dayton, Ohio). 24: 186-98. PMID 16100003 DOI: 10.1634/Stemcells.2004-0236 |
0.534 |
|
| 2006 |
Pandey AC, Dutreil MF, Phinney DG. 155 MURINE MESENCHYMAL STEM CELLS BLOCK T-CELL PROLIFERATION VIA PRODUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST. Journal of Investigative Medicine. 54: S283.4-S283. DOI: 10.2310/6650.2005.X0008.154 |
0.414 |
|
| 2005 |
Phinney DG, Gray AJ, Hill K, Pandey A. Murine mesenchymal and embryonic stem cells express a similar Hox gene profile. Biochemical and Biophysical Research Communications. 338: 1759-65. PMID 16288716 DOI: 10.1016/J.Bbrc.2005.10.140 |
0.498 |
|
| 2005 |
Phinney DG, Isakova I. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Current Pharmaceutical Design. 11: 1255-65. PMID 15853682 DOI: 10.2174/1381612053507495 |
0.547 |
|
| 2005 |
Pandey AC, Baddoo M, Phinney DG. 359 SUBPOPULATIONS OF MURINE MESENCHYMAL STEM CELLS EXPRESS INTERLEUKIN-1 RECEPTOR ANTAGONIST Journal of Investigative Medicine. 53: S317.1-S317. DOI: 10.2310/6650.2005.00006.358 |
0.348 |
|
| 2003 |
Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, Phinney DG. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. Journal of Cellular Biochemistry. 89: 1235-49. PMID 12898521 DOI: 10.1002/Jcb.10594 |
0.478 |
|
| 2003 |
Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proceedings of the National Academy of Sciences of the United States of America. 100: 8407-11. PMID 12815096 DOI: 10.1073/Pnas.1432929100 |
0.415 |
|
| 2003 |
McBride C, Gaupp D, Phinney DG. Quantifying levels of transplanted murine and human mesenchymal stem cells in vivo by real-time PCR. Cytotherapy. 5: 7-18. PMID 12745583 DOI: 10.1080/14653240310000038 |
0.493 |
|
| 2003 |
Ibberson D, Tremain N, Gray A, Phinney DG. What is in a name? Defining the molecular phenotype of marrow stromal cells and their relationship to other stem/progenitor cells. Cytotherapy. 3: 409-11. PMID 11953024 DOI: 10.1080/146532401753277274 |
0.506 |
|
| 2002 |
Phinney DG. Building a consensus regarding the nature and origin of mesenchymal stem cells. Journal of Cellular Biochemistry. Supplement. 38: 7-12. PMID 12046852 DOI: 10.1002/Jcb.10084 |
0.535 |
|
| 2001 |
Tremain N, Korkko J, Ibberson D, Kopen GC, DiGirolamo C, Phinney DG. MicroSAGE analysis of 2,353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages. Stem Cells (Dayton, Ohio). 19: 408-18. PMID 11553849 DOI: 10.1634/Stemcells.19-5-408 |
0.554 |
|
| 2001 |
Prockop DJ, Azizi SA, Phinney DG, Kopen GC, Schwarz EJ. Potential use of marrow stromal cells as therapeutic vectors for diseases of the central nervous system. Progress in Brain Research. 128: 293-7. PMID 11105688 DOI: 10.1016/S0079-6123(00)28026-6 |
0.381 |
|
| 2000 |
Kulkosky J, Bouhamdan M, Geist A, Nunnari G, Phinney DG, Pomerantz RJ. Pathogenesis of HIV-1 infection within bone marrow cells. Leukemia & Lymphoma. 37: 497-515. PMID 11042510 DOI: 10.3109/10428190009058502 |
0.333 |
|
| 2000 |
Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. British Journal of Haematology. 107: 275-81. PMID 10583212 DOI: 10.1046/J.1365-2141.1999.01715.X |
0.459 |
|
| 2000 |
Prockop DJ, Azizi SA, Colter D, DiGirolamo C, Kopen G, Phinney DG. Potential use of stem cells from bone marrow to repair the extracellular matrix and the central nervous system Biochemical Society Transactions. 28: 341-345. DOI: 10.1042/Bst0280341 |
0.524 |
|
| 1999 |
Phinney DG, Kopen G, Righter W, Webster S, Tremain N, Prockop DJ. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. Journal of Cellular Biochemistry. 75: 424-36. PMID 10536366 DOI: 10.1002/(Sici)1097-4644(19991201)75:3<424::Aid-Jcb8>3.0.Co;2-8 |
0.422 |
|
| 1999 |
Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proceedings of the National Academy of Sciences of the United States of America. 96: 10711-6. PMID 10485891 DOI: 10.1073/Pnas.96.19.10711 |
0.51 |
|
| 1999 |
Phinney DG, Kopen G, Isaacson RL, Prockop DJ. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. Journal of Cellular Biochemistry. 72: 570-85. PMID 10022616 DOI: 10.1002/(Sici)1097-4644(19990315)72:4<570::Aid-Jcb12>3.0.Co;2-W |
0.49 |
|
| 1998 |
Li SW, Arita M, Kopen GC, Phinney DG, Prockop DJ. A 1,064 bp fragment from the promoter region of the Col11a2 gene drives lacZ expression not only in cartilage but also in osteoblasts adjacent to regions undergoing both endochondral and intramembranous ossification in mouse embryos. Matrix Biology : Journal of the International Society For Matrix Biology. 17: 213-21. PMID 9707344 DOI: 10.1016/S0945-053X(98)90060-9 |
0.341 |
|
| 1996 |
Laptev A, Phinney D, Isaacson R, Prockop D. Inhibition of marrow osteoprogenitor cell differentiation by murine osteo-blasts Matrix Biology. 15: 190. DOI: 10.1016/S0945-053X(96)90088-8 |
0.49 |
|
| 1995 |
Francis MK, Phinney DG, Ryder K. Analysis of the hormone-dependent regulation of a JunD-estrogen receptor chimera. The Journal of Biological Chemistry. 270: 11502-13. PMID 7744790 DOI: 10.1074/Jbc.270.19.11502 |
0.318 |
|
| 1992 |
Phinney DG, Hoober JK. Regulation of expression by divalent cations of a light-inducible gene in Arthrobacter photogonimos Archives of Microbiology. 158: 85-92. DOI: 10.1007/Bf00245210 |
0.3 |
|
| Show low-probability matches. |